Heron Therapeutics
HRTX
#7234
Rank
A$0.45 B
Marketcap
$3.03
Share price
3.59%
Change (1 day)
73.02%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.77

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.75. In 2022 the company made an earnings per share (EPS) of -$2.59 an increase over its 2021 EPS that were of -$3.37.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.77-31.83%
2022-$2.59-23.11%
2021-$3.37-10%
2020-$3.75-0%
2019-$3.751.21%
2018-$3.70-32.7%
2017-$5.50-19.34%
2016-$6.8254.76%
2015-$4.411.73%
2014-$4.33-16.23%
2013-$5.1791.67%
2012-$2.70-31.45%
2011-$3.94-27.06%
2010-$5.40-43.75%
2009-$9.60-57.33%
2008-$22.50-82.92%
2007-$131.6920.61%
2006-$109.19175.76%
2005-$39.60-21.43%
2004-$50.40100%
2003-$25.20-38.24%
2002-$40.80161.54%
2001-$15.60-106.46%
2000$241.322051.55%
1999$11.22839.73%
1998$1.19-105.48%
1997-$21.80-88.16%
1996-$184.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.95-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.21-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.44 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.35-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.47 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA